E-LIB Suche - Ergebnisse für: Tavelli, Alessandro

1

Impact of COVID-19 pandemic on retention in care of native ..:

Gagliardini, Roberta ; Giacomelli, Andrea ; Bozzi, Giorgio...
Travel Medicine and Infectious Disease. 58 (2024) - p. 102691 , 2024

Link: https://doi.org/10.1016/..

2

Persistent poor clinical outcomes of people living with HIV..:

Mondi, Annalisa ; Cozzi-Lepri, Alessandro ; Tavelli, Alessandro...
International Journal of Infectious Diseases. 142 (2024) - p. 106995 , 2024

Link: https://doi.org/10.1016/..

3

Characterization and outcomes of difficult-to-treat patient..:

Gagliardini, Roberta ; Tavelli, Alessandro ; Rusconi, Stefano...
International Journal of Antimicrobial Agents. 63 (2024) 1 - p. 107018 , 2024

Link: https://doi.org/10.1016/..

4

FRI-442 Disease progression and persistent alanine aminotra..:

Rossotti, Roberto ; Tavelli, Alessandro ; Malagnino, Vincenzo...
Journal of Hepatology. 80 (2024) - p. S791 , 2024

Link: https://doi.org/10.1016/..

5

Do we Still Need Eligibility Criteria to Recommend PrEP? Im..:

Rossotti, Roberto ; Tavelli, Alessandro ; Calzavara, Daniele...
AIDS and Behavior. , 2024

Link: https://doi.org/10.1007/..

6

Heavily treatment-experienced persons living with HIV curre..:

Lo Caputo, Sergio ; Poliseno, Mariacristina ; Tavelli, Alessandro...
International Journal of Infectious Diseases. 143 (2024) - p. 106956 , 2024

Link: https://doi.org/10.1016/..

7

Long-term outcomes of bictegravir/emtricitabine/tenofovir a..:

d'Arminio Monforte, Antonella ; Tavelli, Alessandro ; Di Biagio, Antonio...
Journal of Antimicrobial Chemotherapy. 79 (2024) 6 - p. 1279-1288 , 2024

Link: https://doi.org/10.1093/..

8

SARS-CoV-2 mRNA vaccination and short-term changes in viral..:

Vergori, Alessandra ; Cozzi-Lepri, Alessandro ; Tavelli, Alessandro...
International Journal of Infectious Diseases. 144 (2024) - p. 107065 , 2024

Link: https://doi.org/10.1016/..

9

Real world efficacy of dolutegravir plus lamivudine in peop..:

Gagliardini, Roberta ; Lorenzini, Patrizia ; Cozzi-Lepri, Alessandro...
Journal of Global Antimicrobial Resistance. 32 (2023) - p. 158-163 , 2023

Link: https://doi.org/10.1016/..

10

Long-term outcome of dolutegravir-containing regimens accor..:

D'arminio Monforte, Antonella ; Tavelli, Alessandro ; Sala, Matteo...
Journal of Antimicrobial Chemotherapy. 78 (2023) 4 - p. 933-945 , 2023

Link: https://doi.org/10.1093/..

11

Risk of COVID-19 in-hospital mortality in people living wit..:

Giacomelli, Andrea ; Gagliardini, Roberta ; Tavelli, Alessandro...
International Journal of Infectious Diseases. 136 (2023) - p. 127-135 , 2023

Link: https://doi.org/10.1016/..

12

Hepatitis delta virus (HDV) infection : frequency and outco..:

Puoti, Massimo ; Salpini, Romina ; Tavelli, Alessandro...
Journal of Hepatology. 78 (2023) - p. S1103-S1104 , 2023

Link: https://doi.org/10.1016/..

13

SARS-CoV-2 mRNA Vaccine Response in People Living with HIV ..:

Vergori, Alessandra ; Tavelli, Alessandro ; Matusali, Giulia...
Vaccines. 11 (2023) 11 - p. 1664 , 2023

Link: https://doi.org/10.3390/..

14

Risk Awareness as a Key Determinant of Early Vaccine Uptake..:

Del Duca, Giulia ; Tavelli, Alessandro ; Mastrorosa, Ilaria...
Vaccines. 11 (2023) 12 - p. 1761 , 2023

Link: https://doi.org/10.3390/..

15

Long-term outcome of dolutegravir-containing regimens accor..:

Monforte, Antonella d'Arminio ; Tavelli, Alessandro ; Antinori, Andrea.
Journal of Antimicrobial Chemotherapy. 78 (2023) 7 - p. 1809-1810 , 2023

Link: https://doi.org/10.1093/..